APA
Peterson D. E., Barker N. P., Akhmadullina L. I., Rodionova I., Sherman N. Z., Davidenko I. S., Rakovskaya G. N., Gotovkin E. A., Shinkarev S. A., Kopp M. V., Kulikov E. P., Moiseyenko V. M., Gertner J. M., Firsov I., Tuleneva T., Yarosh A. & Woon C. (20090925). Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Peterson Douglas E, Barker Nicholas P, Akhmadullina Lilia I, Rodionova Irina, Sherman Nailya Z, Davidenko Irina S, Rakovskaya Galina N, Gotovkin Eugeny A, Shinkarev Sergey A, Kopp Mikhail V, Kulikov Eugeny P, Moiseyenko Vladimir M, Gertner Joseph M, Firsov Igor, Tuleneva Tamara, Yarosh Alexander and Woon Chee-Wai. 20090925. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Peterson D. E., Barker N. P., Akhmadullina L. I., Rodionova I., Sherman N. Z., Davidenko I. S., Rakovskaya G. N., Gotovkin E. A., Shinkarev S. A., Kopp M. V., Kulikov E. P., Moiseyenko V. M., Gertner J. M., Firsov I., Tuleneva T., Yarosh A. and Woon C. (20090925). Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Peterson Douglas E, Barker Nicholas P, Akhmadullina Lilia I, Rodionova Irina, Sherman Nailya Z, Davidenko Irina S, Rakovskaya Galina N, Gotovkin Eugeny A, Shinkarev Sergey A, Kopp Mikhail V, Kulikov Eugeny P, Moiseyenko Vladimir M, Gertner Joseph M, Firsov Igor, Tuleneva Tamara, Yarosh Alexander and Woon Chee-Wai. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20090925.